Showing results for : actinium therapy

Radio-theranostics: How Tiny Radioactive Molecules are Personalising Cancer Care

The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent that 'sees' the lesion and the other, a companion therapeutic agent that 'treats' the same lesions. While the concept of theranostics is widely used in various molecular probes in oncology, the most relevant application of theranostics is in nuclear medicine where it is called Radio-theranostics.

Read more
Everything you need to know about Alpha PSMA Therapy

The question that most patients and caregivers ask – What is Targeted Alpha Therapy or Alpha PSMA Therapy? Targeted Alpha PSMA Therapy is a targeted, selective internal cellular level radiotherapy to control advanced prostate and cancer.Targeted Alpha PSMA Therapy uses alpha-emitting radioisotopes like Actinium 225 and is a safe, effective therapy with very minimal side-effects

Read more
Castration Resistant Prostate Cancer Treatment – Ac225 PSMA Therapy (Targeted Alpha Therapy)

In the past one year, the Nuclear Oncology Experts team at the Department of Nuclear Medicine at Fortis Memorial Research Institute has treated 30 new patients of Castrate Resistant Prostate Cancer (CRPC) with Ac225 PSMA Therapy (Targeted Alpha Therapy). And the results are similar to the results being achieved by most good Nuclear Medicine Centres across the world – 75-80% of the patients have shown evidences of a significant Radiological and Biochemical Response with prolonged duration of response.

Read more